Kariv Tomer's Form 4 filing
Keros Therapeutics, Inc. (KROS) · filed Oct 17, 2025
- Accession no.
- 0000921895-25-002765
- Filed
- Oct 17, 2025, 5:53 PM ET
- Trade date
- Oct 15, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $85.0M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kariv TomerCIK 0001568077 | Director, 10% Owner |
| Nussbaum RanCIK 0001609805 | Director, 10% Owner |
| Pontifax (Cayman) IV L.P.CIK 0001726029 | 10% Owner |
| Pontifax (China) IV L.P.CIK 0001726030 | 10% Owner |
| Pontifax (Israel) IV, L.P.CIK 0001726039 | 10% Owner |
| Pontifax Management 4 G.P. (2015) Ltd.CIK 0001726334 | 10% Owner |
| Pontifax Late Stage Fund L.P.CIK 0001793769 | 10% Owner |
| Pontifax Late Stage GP Ltd.CIK 0001793770 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2025 | Common Stock, $0.0001 par value per share | SSaleDisposed | −2,284,612 | $17.75 | −$40,551,863 | 0 | Indirect | |
| Oct 15, 2025 | Common Stock, $0.0001 par value per share | SSaleDisposed | −1,121,045 | $17.75 | −$19,898,548.75 | 0 | Indirect | |
| Oct 15, 2025 | Common Stock, $0.0001 par value per share | SSaleDisposed | −1,226,412 | $17.75 | −$21,768,813 | 0 | Indirect | |
| Oct 15, 2025 | Common Stock, $0.0001 par value per share | SSaleDisposed | −155,262 | $17.75 | −$2,755,900.5 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.